Edgestream Partners L.P. Acquires Shares of 4,374 ICU Medical, Inc. (NASDAQ:ICUI)

Edgestream Partners L.P. purchased a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,374 shares of the medical instruments supplier’s stock, valued at approximately $679,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in ICUI. Venturi Wealth Management LLC lifted its stake in shares of ICU Medical by 1,510.0% during the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after purchasing an additional 302 shares during the last quarter. Point72 Hong Kong Ltd purchased a new stake in shares of ICU Medical during the 3rd quarter worth $72,000. Smartleaf Asset Management LLC lifted its stake in shares of ICU Medical by 166.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier’s stock worth $140,000 after purchasing an additional 567 shares during the last quarter. Coldstream Capital Management Inc. purchased a new stake in shares of ICU Medical during the 3rd quarter worth $227,000. Finally, Atria Investments Inc purchased a new stake in shares of ICU Medical during the 3rd quarter worth $228,000. Institutional investors own 96.10% of the company’s stock.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. The trade was a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 6.70% of the company’s stock.

ICU Medical Stock Performance

Shares of NASDAQ:ICUI opened at $141.59 on Thursday. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The firm has a market capitalization of $3.47 billion, a PE ratio of -30.98 and a beta of 0.73. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The business’s 50 day moving average price is $157.96 and its 200-day moving average price is $165.25.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. Raymond James set a $97.00 price target on ICU Medical in a research note on Wednesday. KeyCorp increased their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, StockNews.com cut ICU Medical from a “buy” rating to a “hold” rating in a research note on Monday. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.